|
Delayed
Bombay S.E.
00:43:35 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 86.01 INR | -2.57% |
|
+5.81% | -0.97% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Credit Agencies | ||||||||||
Manufacturing and Trading of all kind of active Pharmaceutical Ingredients | 2.02M | 2.11M | 36.07M | 237M | 637M | |||||
Total Assets | 53.08M | 52.29M | 99.08M | 366M | 633M | |||||
Interest Expense | - | - | - | - | -7.01M | |||||
Income Tax Expense | 20.89K | 500 | 156K | 3.02M | 30.52M | |||||
CAPEX | - | - | - | -59.16M | -57.75M | |||||
EBT | 81.13K | -171K | 321K | 10.87M | 120M | |||||
D&A | 155K | 146K | 79K | 295K | 2.23M | |||||
Net Income | 60.24K | -171K | 164K | 7.85M | 89.25M |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 2.02M | 2.11M | 36.07M | 237M | 637M | |||||
Total Assets | 53.08M | 52.29M | 99.08M | 366M | 633M | |||||
Interest Expense | - | - | - | - | -7.01M | |||||
Income Tax Expense | 20.89K | 500 | 156K | 3.02M | 30.52M | |||||
D&A | 155K | 146K | 79K | 295K | 2.23M | |||||
CAPEX | - | - | - | -59.16M | -57.75M | |||||
Net Income | 60.24K | -171K | 164K | 7.85M | 89.25M | |||||
EBT | 81.13K | -171K | 321K | 10.87M | 120M |
- Stock Market
- Stocks
- MACINTR Stock
- Financials Astal Laboratories Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
